(EMAILWIRE.COM, March 14, 2019 ) NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGs based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. The report would be of an interest to various stakeholders operating in the NGS based RNA seq market. These stakeholders include manufacturing companies, dealer companies, supplier companies, wholesalers, hospitals, research centers and others.

The report contains 205 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPBT00002556/

Major Players Operating in the NGS-based RNA-seq Market-
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

According to a new market research study titled ‘NGS-Based RNA-Seq Market to 2027 – Global Analysis and Forecasts by Product & Services, Technology, Application and End User, the global NGS-based RNA-seq market was valued at US$ 1,240.87 Mn in 2017 and is estimated to reach US$ 7,984.90 Mn by 2027. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.The report highlights the trends prevalent in the global NGS-based RNA-seq market and the factors driving the market along with those that act as deterrents to its growth.

Global NGS-based RNA-seq market is expected to grow in the coming years, owing to the factors such as, reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, the risks related to genetic data and high cost of NGS instruments is act as a restraint for this market. On the other hand, barcode scanning for long reads sequences likely to add novel opportunities for NGS-based RNA-seq market, in the coming years.

Browse Complete Report at https://www.theinsightpartners.com/reports/ngs-based-rna-seq-market

The report segments the global NGS-based RNA-seq market as follows:

Global NGS-Based RNA-Seq Market – By Product & Services
• Sample Preparation
• Method
• Manual Method
• Automated Method
• Workflow Step
• Library Preparation & Target Enrichment
• Fragmentation, End Repair & Size Selection
• Quality Control
• Sequencing Services
• Sequencing Platform & Consumables
• Data Analysis, Storage & Management

Global NGS-Based RNA-Seq Market – By Technology
• Sequencing By Synthesis
• Nanopore Sequencing
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time (SMRT) Sequencing

Global NGS-Based RNA-Seq Market – By Application
• Diagnostics
• Drug Discovery
• Precision Medicine
• Others

Global NGS-Based RNA-Seq Market – By End User
• Hospitals & Clinics
• Research Centers and Academic & Government Institutes
• Biotechnology & Pharmaceutical Companies
• Others

Global NGS-Based RNA-Seq Market – By Geography
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Asia Pacific (APAC)
• Japan
• China
• India
• Middle East & Africa (MEA)
• U.A.E
• Saudi Arabia
• South Africa
• South and Central America (SCAM)
• Brazil

Buy this Report now at https://www.theinsightpartners.com/buy/TIPBT00002556

Contact Information:
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results